Butyrylcholinesterase anticorps

N° du produit ABIN2718539

Cet anticorps Souris Monoclonal détecte spécifiquement Butyrylcholinesterase dans WB et FACS. Il présente une réactivité envers Humain et Chien.

Aperçu rapide pour Butyrylcholinesterase anticorps (ABIN2718539)

Antigène: Butyrylcholinesterase (BCHE)

Reactivité: Humain, Chien

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Butyrylcholinesterase est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Clone: 1E1

Détail du produit anti-Butyrylcholinesterase anticorps

Attributs du produit: Homo sapiens butyrylcholinesterase (BCHE)

Purification: Purified from mouse ascites fluids by affinity chromatography

Immunogène: Full length human recombinant protein of human BCHE (NP_000046) produced in HEK293T cell.

Isotype: IgG1

Information d'application

Indications d'application: WB 1:500~2000, FLOW 1:100,

Commentaires:

The concentration of the product may vary between diferrent lots.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur Butyrylcholinesterase

Antigène: Butyrylcholinesterase (BCHE)

Autre désignation: BCHE

Sujet: Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.

Poids moléculaire: 68.2 kDa

ID gène: 590

NCBI Accession: NM_000055

HGNC: 590

Pathways: Peptide Hormone Metabolism